Join us in-person in Berlin, Germany for the 14th GSCN Conference, which we are supporting as a Bronze Sponsor. Learn more about our involvement in the event below (further details TBA).
Evotec at 14th GSCN Conference 2026
Oral Presentations
Off-The-Shelf Immune-Shielded iPSC-Derived CAR γδ T Cells as Novel Cell Therapy to Treat Hepatocellular Carcinoma
Presenter: Stephanie Sontag, Senior Research Scientist, iPSC Cell Therapy
Date and Time: Thursday, 10 September, 2026, 10:00 AM- 10:15 AM
Integrating Patient Data and hiPSC Microglia to Model Alzheimer’s Disease for Drug Discovery
Presenter: Henrik Renner, Senior Research Scientist, iPSC Drug Discovery
Date and Time: Thursday, 10 September, 2026, 11:50 AM - 12:05 PM
Human iPSC Models for Safer Drug Discovery Through Predictive Teratogenicity Assessment
Presenter: Bastian Zimmer, VP iPSC Drug Discovery, Innovation
Date and Time: Friday, 11 September, 2026, 09:45 AM - 10:00 AM
Poster Presentations
Off-The-Shelf Immune-Shielded iPSC-Derived Car γδ T Cells as Novel Cell Therapy to Treat Hepatocellular Carcinoma
Presenter: Judith Hartmann, Senior Research Assistant, iPSC Cell Therapy
Date and Time: TBD
Scalable 3D Closed Stirred-Tank Reactor Enabling Multi-Lineage Differentiation for Cell Therapy
Presenter: Thomas Aleyt, Senior Research Assistant Cell Therapy, iPSC Cell Therapy
Date and Time: TBD
GMP iPSC Derived CAR Macrophages with Immune Shielding for Off the Shelf Treatment of Fibrosis
Presenter: Elisabeth Derksen, Research Assistant, iPSC Cell Therapy
Date and Time: TBD
Modeling Human Heart Atlas-Derived Disease Mechanisms in iPSC-Based Cardiac Systems
Presenter: Kinga Wrona, Research Associate, Prot Dev Core
Date and Time: TBD
